Target intelligence / Profile preview

Thujone

Molecular classification
monoterpene, small molecule, organic compound
01

Overview

Thujone is a bicyclic monoterpene ketone (C10H16O) present in several essential oils—most famously in Artemisia absinthium (wormwood), sage, and Thuja species. Thujone exists naturally in two main diastereomeric forms—α-thujone and β-thujone—with additional enantiomers and isomers possible. Thujone acts as a reversible inhibitor at the GABA-A receptor, which can cause convulsant and neurotoxic effects at higher exposures by interfering with neuronal inhibition. It is not itself a drug target, but a bioactive phytochemical with noted toxicological and pharmacological properties. Thujone's best-known historical association is as a constituent of absinthe and the cause of that beverage’s reputed neurotoxicity at high doses, though these effects are primarily due to thujone's antagonism of GABAergic neurotransmission. Important clarification: Thujone is a ligand (natural or synthetic molecule that binds to a biological target), but not a therapeutic target itself. The GABA-A receptor would be the therapeutically relevant target in this context. Querying "Thujone" as a target is therefore incorrect as defined by biomedical target conventions. Summary for structured extraction: Thujone is a phytochemical monoterpene, not a molecular target. Not a receptor, enzyme, or transporter. Biological activity: Inhibits GABA-A receptor function as a non-competitive antagonist, which can cause CNS excitation and convulsions at high doses. Not clinically used as a drug. Associated safety risks: neurotoxicity, convulsant effect, potential toxicity via ingestion especially in high-dose or concentrated extracts.

Other names
3-thujanoneα-thujonebeta-thujoneisothujone(Z)-thujone(E)-thujonecis-thujonetrans-thujonebicyclo[3.1.0]hexan-3-one, 4-methyl-1-(1-methylethyl)-4-Methyl-1-(propan-2-yl)bicyclo[3.1.0]hexane-3-oneNSC 93742471-15-8 (CAS)546-80-5 (CAS)
02

Safety considerations

Convulsant effects at high doses (GABA antagonism)NeurotoxicityOccupational risksIngestion risks (especially with high-dose or concentrated extracts)

Beyond the preview

Go deeper on Thujone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thujone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call